Hearing Loss, Sensorineural
1
Pipeline Programs
3
Companies
6
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
OticonDenmark - Smørum
3 programsNeuro 1 & Neuro 2N/A1 trial
Neuro ZtiN/A1 trial
PupillometryN/A1 trial
Active Trials
iotaMotionIA - Iowa City
2 programsiotaSOFT Insertion SystemN/A1 trial
iotaSOFT Insertion System with AIMN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
BiogenPF-04958242
iotaMotioniotaSOFT Insertion System with AIM
OticonPupillometry
iotaMotioniotaSOFT Insertion System
OticonNeuro 1 & Neuro 2
OticonNeuro Zti
Clinical Trials (6)
Total enrollment: 44 patients across 6 trials
A Study Of The Effects Of PF-04958242 In Subjects With Age-Related Hearing Loss
Start: Dec 2011Est. completion: Feb 201344 patients
Phase 1Completed
Evaluation of the Automated Integration of a Robotics and ECochG System for Use With Cochlear Implant Surgery
Start: Jan 2024Est. completion: Aug 2025
N/ARecruiting
A Monocentric Study Evaluating Pupillometry as an Objective Measurement for CI Fittings
Start: May 2023Est. completion: Nov 2023
N/ATerminated
iotaSOFT Pediatric Study
Start: May 2022Est. completion: Jul 2025
N/ACompleted
Neuro 1 vs. Neuro 2 Sound Processors
Start: Nov 2019Est. completion: Jan 2020
N/ACompleted
The Neuro Zti Cochlear Implant System Efficacy and Safety in Adults
Start: Feb 2017Est. completion: Nov 2019
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 44 patients
3 companies competing in this space